Antioxidant and renoprotective activity of 2-hydroxypropyl-β-cyclodextrin in nephrectomized rats.

about

Antioxidant and renoprotective activity of 2-hydroxypropyl-β-cyclodextrin in nephrectomized rats.

Item

http://www.wikidata.org/entity/Q53472979

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Antioxidant and renoprotective ...... extrin in nephrectomized rats.

@en

Antioxidant and renoprotective ...... extrin in nephrectomized rats.

@nl

type

Item

label

Antioxidant and renoprotective ...... extrin in nephrectomized rats.

@en

Antioxidant and renoprotective ...... extrin in nephrectomized rats.

@nl

prefLabel

Antioxidant and renoprotective ...... extrin in nephrectomized rats.

@en

Antioxidant and renoprotective ...... extrin in nephrectomized rats.

@nl

P1476

Antioxidant and renoprotective ...... extrin in nephrectomized rats.

@en

P2093

Daisuke Iohara

http://www.w3.org/2001/XMLSchema#string

Fumitoshi Hirayama

http://www.w3.org/2001/XMLSchema#string

Kaneto Uekama

http://www.w3.org/2001/XMLSchema#string

Kazuaki Taguchi

http://www.w3.org/2001/XMLSchema#string

Koki Wada

http://www.w3.org/2001/XMLSchema#string

Makoto Anraku

http://www.w3.org/2001/XMLSchema#string

Masaki Otagiri

http://www.w3.org/2001/XMLSchema#string

Toru Maruyama

http://www.w3.org/2001/XMLSchema#string

P2860

Chronic cyclodextrin treatment of murine Niemann-Pick C disease ameliorates neuronal cholesterol and glycosphingolipid storage and disease progression

Collaborative development of 2-hydroxypropyl-β-cyclodextrin for the treatment of Niemann-Pick type C1 disease

The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay

Chronic kidney disease-induced cardiac fibrosis is ameliorated by reducing circulating levels of a non-dialysable uremic toxin, indoxyl sulfate.

2-Hydroxypropyl-beta-cyclodextrin (HP-beta-CD): a toxicology review.

Cyclodextrin-based pharmaceutics: past, present and future.

Enhanced human tissue microdialysis using hydroxypropyl-ß-cyclodextrin as molecular carrier.

Reversal of defective lysosomal transport in NPC disease ameliorates liver dysfunction and neurodegeneration in the npc1-/- mouse.

Design and evaluation of cyclodextrin-based drug formulation.

Lipid and cholesterol trafficking in NPC.

P304

608-614

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/JPHP.12446

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-06-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26058311

http://www.w3.org/2001/XMLSchema#string